Overview of the animal health drug development and registration process: an industry perspective
| Autor: | Brian R Cox, Robert P. Hunter, Jason E Hammelman, Roger M Butler, Thomas R. Shryock |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Pharmacology
Government Drug Industry Management science business.industry media_common.quotation_subject Veterinary Drugs Animal Welfare Commercialization Intervention (law) Quality of life (healthcare) Drug development Drug Discovery Agency (sociology) Government Regulation Animals Molecular Medicine Medicine Regulated Industry Quality (business) Marketing business Drug Approval media_common |
| Zdroj: | Future Medicinal Chemistry. 3:881-886 |
| ISSN: | 1756-8927 1756-8919 |
| Popis: | Products for animal health commercialization follow a structured progression from initial concept through to regulatory approval. Typically, products are developed for use in either food animals or companion animals. These can be for the intention of disease intervention, productivity enhancement or improvement in a quality of life capacity. The animal health industry is a regulated industry, meaning that a government agency is responsible for oversight of products, both pre- and post-approval. There are three primary US government agencies that ensure quality, safety and effectiveness for the approval of new products and post-marketing compliance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|